	Machine Learning-Guided Identification of Madecassoside as a Potential RAD51 Modulator That Sensitizes Breast Cancer Cells to Cisplatin. Chem Biol Drug Des Oh M, Jeong MY, Choi J. PMID: 42870317 [PubMed - indexed for MEDLINE]
	Integrative Multi-Omics and Experimental Validation Define RELB as an Immune-Related Prognostic Driver in Ovarian Cancer. Chem Biol Drug Des Leng W, Fan X, Fang Y. PMID: 42870286 [PubMed - indexed for MEDLINE]
	Longitudinal changes in PCOS-related reproductive and metabolic markers in female patients with bipolar disorder: a six-month observational study. BMC Psychiatry Liu J, Huang J, Teng Z, Fu Y, Tan Y, Qin Y, Chen H, Liu M, Chen J, Wu H, Wu Y, Wang G. PMID: 42870233 [PubMed - indexed for MEDLINE]
	HCF-Net: a Hierarchical Cascade Fusion Network Aligned with Clinical Treatment Pathways for Preoperative Molecular Subtyping of Breast Cancer on Dynamic Contrast-Enhanced MRI. J Imaging Inform Med Chen Y, Hu L, Hou J, Xie Y, Nie S, Jiang Y, Han B, Li X. PMID: 42870154 [PubMed - as supplied by publisher]
	Adenoma laterality and risk of subsequent colorectal cancer: Secondary analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer trial. Surgery Frebault J, Troester A, Huo L, Rudser K, Hassan I, Shaukat A, Goffredo P. PMID: 42868921 [PubMed - as supplied by publisher]
	The prevalence of cardiac dysfunction among breast cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol van der Wal L, Tjepkema M, Maass S, Liemburg G, Huizinga F, Stegmann M, Blanker M, de Bock G, Brandenbarg D. PMID: 42868863 [PubMed - as supplied by publisher]
	Soluble N-terminal EphA2 fragment as a diagnostic biomarker and functional mediator of tumor progression in triple-negative breast cancer. Transl Oncol Lin TY, Chang FL, Hsieh SJ, Zheng JH, Lu YC, Cheng MH, Tsai KC, HuangFu WC, Hung CS, Lee YC. PMID: 42868712 [PubMed - as supplied by publisher]
	Supercharged NK Cells: A Novel NK Cell-Based Immunotherapy to Target Poorly Differentiated and Well-Differentiated Uterine Cancers. Crit Rev Immunol Sher E, Yepez SH, Chen PC, Jewett A, Kaur K. PMID: 42868602 [PubMed - indexed for MEDLINE]
	Network Pharmacology, Molecular Docking, and Molecular Dynamics Studies to Predict the Molecular Mechanisms of Cyclocybe cylindracea Mushroom (Agaricomycetes) Active Compounds for the Treatment of Breast Cancer. Int J Med Mushrooms Rebai R, Toumi ME, Derardja I, Kebaili FF. PMID: 42868540 [PubMed - indexed for MEDLINE]
	Experiences of breast cancer survivors following Nipple-Areola complex tattooing: A qualitative study. Womens Health (Lond) Maselli D, Torreggiani M, Soffientini V, Ghirotto L, Ferri P, Costi S. PMID: 42868178 [PubMed - indexed for MEDLINE]
	Psychological distress among women with abnormal cervical cancer screening results in Poland: Validation of the Polish version of the Cervical Dysplasia Distress Questionnaire (CDDQ-PL). PLoS One Szmigiel-Soja A, Kot J, Sie, Gawron I, Jach R, Malinowska-Lipie, Trojnarska D. PMID: 42868113 [PubMed - indexed for MEDLINE]
	Long-term oncological outcomes after nipple-sparing mastectomy and implant-based immediate breast reconstruction in a population-based cohort of breast cancer patients. BJS Open Sackey H, Oikonomou I, Liu Y, Frisell A, Coudé Adam H, Ansarei D, Halle M, Johansson ALV, de Boniface J. PMID: 42868086 [PubMed - indexed for MEDLINE]
	Comparison of two automated PGMI-based software tools for breast positioning quality assessment in DBT screening. Eur Radiol Exp Gennaro G, Trazzi S, Bordon V, Galli V. PMID: 42867734 [PubMed - indexed for MEDLINE]
	Limited clinical value of routine PET/CT in early-stage breast cancer: a multicenter retrospective study. Breast Cancer Salam K, Numan H, Zreik AE, Skaini MB, Ghais A, Khater CA, Nassar D, Ghanem H, Karak FE, Safa M, Saghir N, Moukadem H, Tfayli A. PMID: 42867613 [PubMed - as supplied by publisher]
	Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential. Med Chem Res Shagufta, Ahmad I, Khan I, Al Zubaidi M, Aladhamy A. PMID: 42867504 [PubMed - as supplied by publisher]
	Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial. Radiology van Grinsven SEL, Monninkhof EM, Mann RM, Lobbes MBI, Broeders MJM, van Ravesteyn NT, Bluekens AMJ, van Diest PJ, Dorrius MD, Duvivier KM, Gielens MPM, de Jong MDF, Kock MCJM, Loo CE, Meeuwis C, de Monyé C, van Nijnatten TJA, Pijnappel RM, Trap-de Jong JP, Veltman J, Veldhuis WB, van Gils CH, DENSE-2 Trial Study Group, DENSE-2 trial study group. PMID: 42867374 [PubMed - indexed for MEDLINE]
	The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2). J Med Virol Miklu, Poljak M, Mlakar J, Cokan A, Paki, Knez J, Al-Mahdawi L, Ro, Gorenjak M, O, Domjani, Dovnik A. PMID: 42867141 [PubMed - indexed for MEDLINE]
	The Prognostic Role of Vimentin Expression in Triple-Negative Breast Cancer: A Retrospective Cohort Study. Cancer Rep (Hoboken) Danil Yulian E, Hellyanti T, Rowika KHL. PMID: 42867021 [PubMed - indexed for MEDLINE]
	Repeat breast-conserving surgery for ipsilateral breast tumour recurrence: towards a paradigm shift-a narrative review. Gland Surg Venkataraman J, Massad AM, Mokbel K. PMID: 42866827 [PubMed]
	Relative change rate of neutrophil-to-albumin ratio (Î”NAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer. Gland Surg Zhao Y, Deng Y, Chen W, Liu M, Peng Z, Liu Y, Zhang L. PMID: 42866807 [PubMed]

Articles 1 - 20 / 336470

Page 1 of 16824



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy